Incyte Investors

Incyte is a prominent venture capital fund established in 1991 and located in Wilmington, Delaware, United States The firm specializes in investing in innovative biotechnology and pharmaceutical companies, with a focus on advancing novel therapeutic solutions Incyte has a significant investment scale, managing substantial assets that enable it to support early-stage and growth-stage ventures The fund is recognized for its strategic partnerships and commitment to fostering the development of transformative healthcare technologies

Employee Number: 501-1000
Funding Status: IPO
Headquarters: USA
Technology: Cancer
Estimated Revenue: $500M to $1B
Founded Date: 1991
Investor Type: Venture Capital Funds
Industry: FemTech